Divalproex Sodium
NDC Package 70518-3620-2

11-digit billing NDC: 70518362002

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Divalproex Sodium is delayed release tablets should not be administered to patients with hepatic disease or significant hepatic dysfunction [see Warnings and Precautions ( 5.1)]. Marketed by Remedyrepack Inc., this product is identified by NDC 70518-3620 and is authorized under FDA application ANDA079163.

Identification & Billing

NDC Package Code
70518-3620-2
Package Description
30 TABLET, DELAYED RELEASE in 1 BLISTER PACK
Product Code
11-Digit Billing Format
70518362002

Clinical Specifications

Proprietary Name
Divalproex Sodium
Dosage Form
-
Usage Information
Divalproex sodium delayed release tablets should not be administered to patients with hepatic disease or significant hepatic dysfunction [see Warnings and Precautions ( 5.1)]. Divalproex sodium delayed release tablets are contraindicated in patients known to have mitochondrial disorders caused by mutations in mitochondrial DNA polymerase γ (POLG; e.g., Alpers-Huttenlocher Syndrome) and children under two years of age who are suspected of having a POLG-related disorder [see Warnings and Precautions ( 5.1)]. Divalproex sodium delayed release tablets are contraindicated in patients with known hypersensitivity to the drug [see Warnings and Precautions ( 5.12)]. Divalproex sodium delayed release tablets are contraindicated in patients with known urea cycle disorders [see Warnings and Precautions ( 5.6)]. For use in prophylaxis of migraine headaches: Divalproex sodium delayed release tablets are contraindicated in women who are pregnant and in women of childbearing potential who are not using effective contraception [see Warnings and Precautions ( 5.2, 5.3, 5.4) and Use in Specific Populations ( 8.1)] .

Regulatory & Marketing

Labeler Name
Remedyrepack Inc.
FDA Application #
ANDA079163
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
01-21-2023
End Marketing Date
01-10-2025
Listing Expiration
01-10-2025
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70518-3620). Click a package code to view its specific billing and regulatory data.

100 POUCH in 1 BOX / 1 TABLET, DELAYED RELEASE in 1 POUCH (70518-3620-1)
60 TABLET, DELAYED RELEASE in 1 BLISTER PACK
30 TABLET, DELAYED RELEASE in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70518-3620-2 identifies a specific commercial package of 30 tablet, delayed release in 1 blister pack of Divalproex Sodium, labeled by Remedyrepack Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Remedyrepack Inc. on January 21, 2023. The current certification is valid through January 10, 2025.

How is this Remedyrepack Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70518362002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
70518-3620-2
11-Digit CMS (5-4-2)
70518-3620-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.